Skip to main content
ImmuneCited

Vitamin D pour Immune Aging (Immunosenescence)

B

Research suggests vitamin D supplementation in elderly populations may help improve immune markers and vaccine response. Deficiency is highly prevalent in older adults and is associated with impaired immune function and increased infection susceptibility.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'immunecited.com'; const params = 'ingredient\u003Dvitamin\u002Dd\u0026condition\u003Dimmunosenescence'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

B

En conclusion

Research suggests vitamin D supplementation in elderly populations may help improve immune markers and vaccine response. Deficiency is highly prevalent in older adults and is associated with impaired immune function and increased infection susceptibility.

Key Study Findings

Review
Fanconi anaemia as a human model of accelerated epigenetic and immune ageing.
Dose: None vs: None Outcome: None Effet: None None

Population: patients with Fanconi anaemia

Randomized Controlled Trial n=124
Effects of a Novel Dispersible Supplement Containing 2500 IU of Vitamin D and 1000 µg …
Dose: 2500 IU vitamin D + 1000 mcg B12 vs: Separate D+B12 and no supplementation control Outcome: Serum 25-OH-D and B12 level restoration Effet: 37.1% adequate vs 29.4% separate None

Population: Adults with vitamin D (<20ng/mL) and B12 (<250ng/L) insufficiency

Observational Study n=72
Cardiovascular Risk and Systemic Inflammation in Alopecia Areata: An Observational Case-control Study.
Dose: None vs: Healthy controls Outcome: CVR and systemic inflammation in alopecia areata Effet: None None

Population: 36 AA patients vs 36 matched controls, mean age 39

Controlled Clinical Trial
Vitamin D stimulates Il-15 synthesis in rodent muscle.
Dose: Single dose (rats); variable (in vitro) vs: Untreated controls; VDR-KO mice Outcome: IL-15 gene expression in skeletal muscle Effet: None None

Population: C2C12 myotubes, rats, VDR-KO mice

Randomized Controlled Trial 8 weeks
Comparison of Safety and Efficacy of Topical Mometasone 0.1% Ointment, Calcipotriol 0.005% Ointment, and Tacrolimus …
Dose: Topical ointment application (3 arms) vs: 3-arm: mometasone vs calcipotriol vs tacrolimus Outcome: SALT score change at 8 weeks Effet: None <0.001 (momet, calcipot)

Population: Patients with localized alopecia areata

Other
Modelling the influence of vitamin D and probiotics on inflammation and the intestinal microbiota in …
Dose: None vs: No supplementation (modeled) Outcome: Epithelial barrier integrity and immune response Effet: None None

Population: Older adults (mathematical model)

Key Statistics

10

Études

5000

Participants

Positive

B

Note

Referenced Papers

Biochemistry and biophysics … 2025
International journal of … 2023 54 citations
Autoimmunity reviews 2023 24 citations
Physiological research 2021 2 citations
Advances in chronic … 2019 326 citations
Actas dermo-sifiliograficas 2019 43 citations
European journal of … 2017 66 citations
Postepy dermatologii i … 2017 31 citations
World journal of … 2016 238 citations
Ageing research reviews 2016 142 citations
Postepy dermatologii i … 2016 59 citations
Indian dermatology online … 2016 51 citations
World journal of … 2015 62 citations
The American journal … 2014 125 citations
European journal of … 2012 225 citations
Inflammatory bowel diseases 2012 224 citations
Gerontology 2011 27 citations
Gastroenterology 2010 390 citations
Artificial organs 2006 76 citations
Aging cell 2004 102 citations

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Posologies couramment utilisées

general:
600-800 IU/day
immunesupport:
1,000-2,000 IU/day
deficiencycorrection:
4,000-5,000 IU/day (under medical supervision)

Limite supérieure : 4,000 IU/day (100 mcg)

Posologies étudiées dans la recherche

Posologie Durée Effet N
None -- Negative --
2500 IU vitamin D + 1000 mcg B12 -- Positive 124
None -- Negative 72
Single dose (rats); variable (in vitro) -- Positive --
Topical ointment application (3 arms) 8 weeks Positive --
None -- Positive --
None -- Mixed --
None -- Mixed --

Moment optimal de prise : With a meal containing fat for better absorption

Safety & Side Effects

Effets indésirables signalés

  • Hypercalcemia at very high doses (nausea, vomiting, weakness)
  • Kidney stones with excessive long-term use
  • Constipation
  • Metallic taste

Interactions connues

  • Thiazide diuretics (may increase risk of hypercalcemia)
  • Corticosteroids (reduce vitamin D absorption and metabolism)
  • Orlistat and cholestyramine (reduce fat-soluble vitamin absorption)
  • Statins (vitamin D may affect statin metabolism)

Apport maximal tolérable : 4,000 IU/day (100 mcg)

Consultez toujours votre professionnel de santé avant de commencer tout complément alimentaire.Consultez toujours votre professionnel de santé avant de commencer tout complément alimentaire.

Frequently Asked Questions

Does Vitamin D help with Immune Aging (Immunosenescence)?
Based on 10 studies with 5,000 participants, there is moderate evidence from clinical studies that Vitamin D may support Immune Aging (Immunosenescence) management. Our evidence grade is B (Good Evidence).
How much Vitamin D should I take for Immune Aging (Immunosenescence)?
Studies have used various dosages. A commonly studied range is 600-800 IU/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Vitamin D?
Reported side effects may include Hypercalcemia at very high doses (nausea, vomiting, weakness), Kidney stones with excessive long-term use, Constipation, Metallic taste. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Vitamin D and Immune Aging (Immunosenescence)?
We rate the evidence as Grade B (Good Evidence). This rating is based on 10 peer-reviewed studies with 5,000 total participants. The overall direction of effect is positive.

Related Evidence

Avertissement FDA: Ces déclarations n'ont pas été évaluées par la Food and Drug Administration. Les produits et informations sur ce site ne sont pas destinés à diagnostiquer, traiter, guérir ou prévenir quelque maladie que ce soit. Les notes de preuve présentées sont basées sur notre analyse de la recherche publiée et évaluée par des pairs et ne constituent pas un avis médical. Consultez toujours votre professionnel de santé avant de commencer tout régime de compléments alimentaires.